1. Home
  2. ABLV vs NEPH Comparison

ABLV vs NEPH Comparison

Compare ABLV & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABLV

Able View Global Inc.

HOLD

Current Price

$0.75

Market Cap

36.5M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$2.98

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABLV
NEPH
Founded
2015
1997
Country
China
United States
Employees
89
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
31.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
ABLV
NEPH
Price
$0.75
$2.98
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
398.2K
21.2K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.11
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
$16.70
$27.06
Revenue Growth
N/A
32.67
52 Week Low
$0.54
$1.78
52 Week High
$1.77
$6.42

Technical Indicators

Market Signals
Indicator
ABLV
NEPH
Relative Strength Index (RSI) 51.71 50.51
Support Level $0.60 $2.79
Resistance Level $0.93 $3.18
Average True Range (ATR) 0.09 0.20
MACD 0.01 0.04
Stochastic Oscillator 42.74 82.60

Price Performance

Historical Comparison
ABLV
NEPH

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: